《大行報告》大摩上調聯想集團(00992.HK)目標價至10元 對個人電腦復甦維持正面
摩根士丹利發表報告指,聯想集團(00992.HK)第二季度收入及純利都好過該行預期,2024財政年度的純利指引由12億美元,下調到9億至10億美元,雖然下調指引屬市場預期之中,但略低於該行原先預期的11億美元,相信管理層持保守態度,主要反映基礎設施方案業務(ISG)復甦較預期慢,對於該業務何時扭虧,未有清晰指引,該行估計直至明年第三季繼續虧損。
該行預期聯想2024財年收入約559億美元,按年跌10%,淨利潤率1.8%,純利10億美元,相信股價對於指引下調有負面反應,但認為可以趁低吸納,對2024至2025年個人電腦市場復甦維持正面,目標價由9元上調至10元,維持評級「增持」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.